News
2139 items found, showing page 90 of 179

Scottish Enterprise welcomes offshore wind farm consents
Scottish Enterprise has welcomed the news that four offshore wind farms have received consent from the Scottish Government.

New report reveals scale of decommissioning market for North Sea oil and gas projects
Report calls for talent, innovation and procurement strategy improvements to overcome market challenges
By 2040, investment of around £30 billion is expected in the UK Continental Shelf (UKSC) on decommissioning North Sea oil and gas projects according to a new report commissioned by Decom North Sea and Scottish Enterprise.

Energy Minister announces Scottish contribution to €7 million research and development fund.
Scottish ocean energy companies will be able to bid for a share of a new €7 million funding pot, Energy Minister Fergus Ewing will say today.

Jee Ltd awarded pioneering cable solutions contract
Jee Ltd, a leading independent multi-discipline subsea engineering and training firm, has been awarded a contract from Scottish Enterprise to develop subsea electrical array cable solutions for tidal energy installations.

£10m Scottish expansion for Hyspec
New state-of-the-art Kilmarnock premises and 80 jobs for Scottish-based firm

5,833 jobs for Scotland
Almost half of Q1 and Q2 jobs a result of US engagement

Scottish Investment Bank supports the development of a new drug to fight antimicrobial resistance
Scottish Biopharmaceutical Company MGB Biopharma Secures £4.0m ($6.4m) to Develop New Antibacterial Drug against the Major Global Problem of Antimicrobial Resistance
MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, announces today that it has secured £4.0m ($6.4m) to advance the development of its lead antibacterial, MGB-BP-3, against a range of Gram-positive infections including Clostridium difficile and methicillin-resistant and susceptible Staphylococcus species. MGB-BP-3 is the first novel class of antibacterial for over a decade with a new mode of action to be developed globally. The drug - originally developed at the University of Strathclyde and licensed to MGB Biopharma - could make a real difference in the fight against antimicrobial resistance.

£20.5 million for tidal power
First phase of new development that could eventually power 175,000 homes.
